Doximity, Inc. (DOCS)

NYSE: DOCS · Real-Time Price · USD
64.02
+2.20 (3.56%)
At close: Aug 13, 2025, 4:00 PM
64.27
+0.25 (0.40%)
After-hours: Aug 13, 2025, 4:11 PM EDT
3.56%
Market Cap 11.99B
Revenue (ttm) 589.64M
Net Income (ttm) 235.13M
Shares Out 187.30M
EPS (ttm) 1.17
PE Ratio 54.76
Forward PE 41.94
Dividend n/a
Ex-Dividend Date n/a
Volume 1,770,393
Open 62.00
Previous Close 61.82
Day's Range 61.88 - 64.73
52-Week Range 34.34 - 85.21
Beta 1.36
Analysts Buy
Price Target 66.74 (+4.25%)
Earnings Date Aug 7, 2025

About DOCS

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, ... [Read more]

Sector Healthcare
IPO Date Jun 24, 2021
Employees 830
Stock Exchange NYSE
Ticker Symbol DOCS
Full Company Profile

Financial Performance

In 2024, Doximity's revenue was $570.40 million, an increase of 19.98% compared to the previous year's $475.42 million. Earnings were $223.19 million, an increase of 51.23%.

Financial Statements

Analyst Forecast

According to 19 analysts, the average rating for DOCS stock is "Buy." The 12-month stock price target is $66.74, which is an increase of 4.25% from the latest price.

Price Target
$66.74
(4.25% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings

Doximity Inc DOCS reported better-than-expected earnings for the first quarter on Thursday.

5 days ago - Benzinga

Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript

Doximity, Inc. (NYSE:DOCS) Q1 2026 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Anna Bryson - Chief Financial Officer Jeffrey A. Tangney - Co-Founder, CEO & Chairperson Per...

5 days ago - Seeking Alpha

Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers

Doximity has acquired the AI startup Pathway Medical for $63 million.  Pathway has one of the largest structured datasets in medicine, Doximity said.

6 days ago - CNBC

Doximity Acquires Pathway, a Leader in AI Clinical Reference

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based st...

6 days ago - Business Wire

Doximity Announces Fiscal 2026 First Quarter Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter ended June 30, 2025. ...

6 days ago - Business Wire

New Doximity Study Shows Modest Physician Pay Growth Amid Deeper Workforce Strain, Reimbursement Pressures

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its 2025 Physician Compensation Report. The findings highlight ...

13 days ago - Business Wire

Doximity: Slowing Sales And EBITDA Growth

Doximity shares have dropped nearly 25% from February highs, despite strong Q4 earnings and 17% revenue growth year-over-year. Analyst sentiment is mixed, and insider selling has notably increased in ...

21 days ago - Seeking Alpha

Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter e...

27 days ago - Business Wire

Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certai...

4 weeks ago - GlobeNewsWire

Doximity Crushes The Rule Of 40 - Try Rule Of 58

I have a price target of $85 for Doximity by summer 2026. There is lots to be bullish about. Doximity's fundamentals are strong: zero debt, a large cash cushion, and robust free cash flow generation s...

6 weeks ago - Seeking Alpha

Doximity: A Unique, Debt-Free Healthcare-Tech Platform, Initiate With 'Buy'

I rate Doximity a 'Buy' with a $62 fair value, citing its dominant network among U.S. healthcare professionals and robust growth trajectory. Doximity's strong pharma marketing business, workflow solut...

2 months ago - Seeking Alpha

Doximity to Present at the William Blair 45th Annual Growth Stock Conference

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the Wil...

3 months ago - Business Wire

Doximity Stock 7.8% Higher After Key Trading Signal

DOCS reverses steep decline after TradePulse Alert

3 months ago - Benzinga

These Analysts Cut Their Forecasts On Doximity After Q4 Results

Doximity, Inc. DOCS reported better-than-expected earnings for the fourth quarter on Thursday.

3 months ago - Benzinga

Globant, Doximity, Applied Materials And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday.

Other symbols: AMATGLOB
3 months ago - Benzinga

Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript

Doximity, Inc. (NYSE:DOCS) Q4 2025 Earnings Conference Call May 15, 2025 5:00 PM ET Company Participants Perry Gold - Head of IR Jeff Tangney - Co-Founder and CEO Anna Bryson - CFO Nate Gross - Co-Fo...

3 months ago - Seeking Alpha

Doximity Stock Drops 20% After Outlook Disappoints

Shares of Doximity plummeted late Thursday after the telehealth software company dished out a disappointing outlook.

3 months ago - Investopedia

Doximity Announces Fourth Quarter and Fiscal Year 2025 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 fourth quarter and fiscal year ende...

3 months ago - Business Wire

Doximity: Strong Fundamentals And Pharma Tailwinds Meet An Overpriced Valuation

Doximity is experiencing strong user engagement growth, driven by demand from medical prescribers and pharmaceutical marketers. Pharma marketing, Doximity's largest opportunity, is fueling sustained m...

3 months ago - Seeking Alpha

Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter ...

3 months ago - Business Wire

DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DOCS

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Doximity, Inc. ...

6 months ago - Business Wire

Doximity: Rating Downgrade As Near-Term Upside Is Priced In

I downgraded Doximity from buy to hold due to expected growth slowdown and current high valuation at 40.5x forward EBITDA. DOCS reported strong Q3 performance with $168.6 million revenue, 25% y/y grow...

6 months ago - Seeking Alpha

Doximity Momentum, Big Money Support Stays Strong

Shares of Doximity, Inc. (DOCS) jump on business growth, investor inflows.

6 months ago - FXEmpire

Doximity to Participate in the Raymond James 46th Annual Institutional Investors Conference

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will present at the Raymond James 46th ...

6 months ago - Business Wire

Doximity Q3 Earnings: Outpacing Even Management's Expectations

I previously rated Doximity, Inc. a buy due to strong Q2 earnings, favorable DCF analysis, and its strategic position in the healthcare industry. Q3 earnings showed continued strength, with DOCS stock...

6 months ago - Seeking Alpha